Pnc Financial Services Group, Inc. Design Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,219 shares of DSGN stock, worth $33,925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,219
Previous 9,219
-0.0%
Holding current value
$33,925
Previous $49,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DSGN
# of Institutions
103Shares Held
30.5MCall Options Held
2.3KPut Options Held
16.5K-
Sr One Capital Management, LP6.53MShares$24 Million11.88% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$15.5 Million3.0% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$8.48 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.89MShares$6.96 Million0.55% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$6.42 Million0.1% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $205M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...